Using a murine model of Blastocystis infection, an Egyptian research team has reported that the anti-cholesterol statin drug Atorvastatin increases the efficacy of metronidazole in treatment of Blastocystis infection in a murine model. The researchers report that, “Anti-Blastocystis efficacy of AVA was evaluated parasitologically, histopathologically and by transmission electron microscopy using MTZ (10 mg/kg) as a control. Therapeutic efficacy of AVA was apparently dose-dependent. Regimens of AVA (20 and 40 mg/kg) proved effective against Blastocystis infections with high reduction in Blastocystis shedding (93.4-97.9%) compared to MTZ (79.3%). The highest reductions (98.1% and 99.4%) were recorded in groups of combination treatments AVA 20-40 mg/kg and MTZ 10 mg/kg. Blastocystis was nearly eradicated by the 20th day post infection. Genotype analysis revealed that genotype I was most susceptible, genotype III was less. ” The study was published in the Korean Journal of Parasitology.
-
Most Downloaded Items
Complete list of studies that identify Blastocystis as pathogenic
Eradication of Blastocystis with Nitazoxanide
Three Drug Combination for Eradication of Blastocystis
Information For Everyone
Show me all publicly available Blastocystis papers that I can download
Signup for our free newsletter (6-8 issues per year)
Show me all of BRF's Research Papers on the NIH's Pubmed Database
View/Download Back Issues of BRF Newsletters
Information For Patients
Blastocystis 'hominis'Symptoms, Treatment and Fact Sheet
Physicians who treat Blastocystis infection
Patient descriptions of Blastocystis 'hominis'infection
Information For Researchers
Use Google Maps to study research trends in Blastocystis 'hominis'
BRF Studies classified by topic
Assays for detection ofBlastocystis 'hominis''
Scientific Device Lab
(parasitology supplies)
Information For Physicians
Differential diagnosis of Blastocystis infection
Treatment of Blastocystis infection
Information For Journalists
Primary Documents (newspaper articles, TV interviews, letters)
Privacy and Engagement Policy Summary: Click here for full text PRIVACY: We may share information about your experiences if you click "OK to Share" in our contact form. Of course, this would not include identifying information (full name, e-mail address) but may include geographical region and first name, unless you ask that this information not be included. If you would like previously posted information to be removed, please use our contact form, and allow for 6-8 weeks for processing. We use the open source WordPress software for content management. We do not intentionally collect or use cookies, however we can not guarantee behavior of WordPress, as its development is beyond our control. MEDICAL: Please contact a physician for health care advice. BRF's collects, analyzes, and distributes information on peer reviewed studies concerning Blastocystis research. We also assist researchers with technical support and grants. BRF is not a medical provider, and can not provide online medical treatment. Patients are encouraged to seek treatment from qualified health professionals.